{"doi":"10.1073/pnas.2424286122","title":"eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer","abstract":") or from reactivation of downstream targets. Newer ER antagonists occasionally show efficacy but are largely ineffective as single agents in the long term. Here, we show that ER translation is eIF4E/cap-independent yet sensitive to inhibitors of the translation initiation factor eIF4A. EIF4A inhibition reduces the expression of ER and cell cycle regulators such as cyclin D1. This leads to growth suppression in ligand-independent breast cancer models, including those driven by ER mutants and fusion proteins. Efficacy is enhanced by adding the ER degrader, fulvestrant. The combination further lowers ER expression and blocks tumor growth in vitro and in vivo. In an early clinical trial (NCT04092673), the eIF4A inhibitor zotatifin was combined with either fulvestrant or fulvestrant plus CDK4 inhibitor, abemaciclib, in patients with acquired resistance to these agents. Multiple clinical responses including a handful of durable regressions were observed, with little toxicity. Thus, eIF4A inhibition could be useful for treating ER+ breast cancer resistant to other modalities.","journal":"Proceedings of the National Academy of Sciences","year":2025,"id":516756,"datarank":0.38221284217618007,"base_score":2.302585092994046,"endowment":2.302585092994046,"self_citation_contribution":0.3453877639491069,"citation_network_contribution":0.03682507822707316,"self_endowment_contribution":0.3453877639491069,"citer_contribution":0.03682507822707316,"corpus_percentile":null,"corpus_rank":null,"citation_count":9,"citer_count":8,"citers_with_citation_signal":2,"citers_with_endowment":2,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9606,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":269858,"name":"Ezra Y. Rosen","orcid":"0000-0002-5289-1541","position":1,"is_corresponding":false},{"id":486491,"name":"Malvika Sharma","orcid":"0000-0002-2695-1635","position":2,"is_corresponding":false},{"id":368343,"name":"M. Dorso","orcid":"0000-0002-4343-930X","position":3,"is_corresponding":false},{"id":1333156,"name":"Nicholas Mai","orcid":"0000-0002-1900-7945","position":4,"is_corresponding":false},{"id":218291,"name":"Corina Amor","orcid":"0000-0002-7654-6216","position":5,"is_corresponding":false},{"id":1211681,"name":"Jason Reiter","orcid":null,"position":6,"is_corresponding":false},{"id":257020,"name":"Ram Kannan","orcid":null,"position":7,"is_corresponding":false},{"id":630305,"name":"Sunyana Gadal","orcid":"0000-0003-3073-4067","position":8,"is_corresponding":false},{"id":1333157,"name":"Jianing Xu","orcid":"0000-0003-2210-361X","position":9,"is_corresponding":false},{"id":284894,"name":"Matthew M. Miele","orcid":"0000-0001-7495-2133","position":10,"is_corresponding":false},{"id":618828,"name":"Zhuoning Li","orcid":"0009-0005-9064-8170","position":11,"is_corresponding":false},{"id":658177,"name":"Xiaoping Chen","orcid":"0000-0003-3048-2699","position":12,"is_corresponding":false},{"id":451224,"name":"Qing Chang","orcid":"0000-0001-7406-8479","position":13,"is_corresponding":false},{"id":291726,"name":"Fresia Pareja","orcid":"0000-0003-3748-8049","position":14,"is_corresponding":false},{"id":753615,"name":"Stephen T. Worland","orcid":"0000-0001-8924-253X","position":15,"is_corresponding":false},{"id":1333158,"name":"Douglas Warner","orcid":"0000-0002-9136-9713","position":16,"is_corresponding":false},{"id":1333507,"name":"Sam Sperry","orcid":null,"position":17,"is_corresponding":false},{"id":746871,"name":"Gary G. Chiang","orcid":"0000-0003-3004-7400","position":18,"is_corresponding":false},{"id":1333508,"name":"Peggy A. Thompson","orcid":null,"position":19,"is_corresponding":false},{"id":671223,"name":"Guangli Yang","orcid":"0000-0002-5097-5266","position":20,"is_corresponding":false},{"id":335056,"name":"Ouathek Ouerfelli","orcid":"0000-0002-7038-0219","position":21,"is_corresponding":false},{"id":230273,"name":"Alexander Drilon","orcid":"0000-0001-6806-9061","position":22,"is_corresponding":false},{"id":225995,"name":"Elisa de Stanchina","orcid":"0000-0002-3873-315X","position":23,"is_corresponding":false},{"id":244215,"name":"Hans-Guido Wendel","orcid":null,"position":24,"is_corresponding":false},{"id":277353,"name":"Sarat Chandarlapaty","orcid":"0000-0003-4532-8053","position":25,"is_corresponding":false},{"id":227117,"name":"Neal Rosen","orcid":"0000-0002-8307-654X","position":26,"is_corresponding":false},{"id":1382625,"name":"Jacob Boyer","orcid":"0009-0003-6695-1423","position":0,"is_corresponding":true}],"reference_count":63,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T02:48:54.768083Z","pmid":"40690678","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}